Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quantum-Si (QSI) Change in Receivables (2023 - 2026)

Quantum-Si (QSI) reported Change in Receivables of -$358000.0 for Q1 2026, down 18.94% year-over-year from -$441631.1 in Q1 2025, and down 645.83% on a QoQ basis from -$48000.0 in Q4 2025.

Quantum-Si (QSI) has 4 years of Change in Receivables data on file, last reported at -$358000.0 in Q1 2026.

  • Quarterly Change in Receivables fell 18.94% year-over-year to -$358000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$683000.0 (down 174.73% YoY) and the FY2025 annual result came in at -$626000.0, down 157.48% from the prior year.
  • Change in Receivables fell to -$358000.0 in Q1 2026 per QSI's latest filing, from -$48000.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $435000.0 in Q4 2024 and bottomed at -$358000.0 in Q1 2026.
  • The 4-year median for Change in Receivables is -$48000.0 (2025), against an average of $36384.6.
  • Peak annual rise in Change in Receivables reached 543.88% in 2024, while the deepest fall reached 253.66% in 2024.
  • Tracing QSI's Change in Receivables over 4 years: stood at -$98000.0 in 2023, then jumped by 543.88% to $435000.0 in 2024, then plunged by 111.03% to -$48000.0 in 2025, then plunged by 645.83% to -$358000.0 in 2026.
  • Per Business Quant, the three latest QSI Change in Receivables figures stand at -$358000.0 (Q1 2026), -$48000.0 (Q4 2025), and -$162000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 42.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -444.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -13.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 117.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 117.90 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -124.60 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -141.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 123.50 Mn
10 Quantum-Si 255.44 Mn 128.10 Mn 74,000.00 -358,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -358,000.00
Mar 31, 2026 -358,000.00
Dec 31, 2025 -48,000.00
Dec 31, 2025 -48,000.00
Sep 30, 2025 -162,000.00
Sep 30, 2025 -162,000.00
Jun 30, 2025 -115,000.00
Jun 30, 2025 -115,000.00
Mar 31, 2025 -301,000.00
Mar 31, 2025 -301,000.00
Dec 31, 2024 435,000.00
Dec 31, 2024 435,000.00
Sep 30, 2024 424,000.00
Sep 30, 2024 424,000.00
Jun 30, 2024 356,000.00
Jun 30, 2024 356,000.00
Mar 31, 2024 -126,000.00
Mar 31, 2024 -126,000.00
Dec 31, 2023 -98,000.00
Dec 31, 2023 -98,000.00
Sep 30, 2023 139,000.00
Sep 30, 2023 139,000.00
Jun 30, 2023 245,000.00
Jun 30, 2023 245,000.00
Mar 31, 2023 82,000.00
Mar 31, 2023 82,000.00